Bruker Corporation (BIT:1BRKR)
Italy
· Delayed Price · Currency is EUR 34.98
+0.04 (0.11%)
At close: May 2, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Total BSI | 3.10B |
Log In |
Log In |
Log In |
Log In |
| Total BSI Growth | 14.69% |
Log In |
Log In |
Log In |
Log In |
| BEST | 283.00M |
Log In |
Log In |
Log In |
Log In |
| BEST Growth | 0.82% |
Log In |
Log In |
Log In |
Log In |
| Eliminations from | -14.10M |
Log In |
Log In |
Log In |
Log In |
| Eliminations from Growth | -17.06% |
Log In |
Log In |
Log In |
Log In |
| BSI Life Science | 2.00B |
Log In |
Log In |
Log In |
Log In |
| BSI Life Science Growth | 13.66% |
Log In |
Log In |
Log In |
Log In |
| BSI Nano | 1.10B |
Log In |
Log In |
Log In |
Log In |
| BSI Nano Growth | 16.60% |
Log In |
Log In |
Log In |
Log In |
| BSI BioSpin | 905.70M |
Log In |
Log In |
Log In |
Log In |
| BSI BioSpin Growth | 13.43% |
Log In |
Log In |
Log In |
Log In |
| BSI CALID | 1.09B |
Log In |
Log In |
Log In |
Log In |
| BSI CALID Growth | 13.86% |
Log In |
Log In |
Log In |
Log In |
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Total BSI Capital Expenditures | 91.00M |
Log In |
Log In |
Log In |
Log In |
| Total BSI Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In |
| BEST Capital Expenditures | 24.30M |
Log In |
Log In |
Log In |
Log In |
| BEST Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In |
| BSI Life Science Capital Expenditures | 56.90M |
Log In |
Log In |
Log In |
Log In |
| BSI Life Science Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In |
| BSI Nano Capital Expenditures | 19.30M |
Log In |
Log In |
Log In |
Log In |
| BSI Nano Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In |
| Corporate Capital Expenditures | 14.80M |
Log In |
Log In |
Log In |
Log In |
| Corporate Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In |
| BSI BioSpin Capital Expenditures | 22.80M |
Log In |
Log In |
Log In |
Log In |
| BSI BioSpin Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In |
| BSI CALID Capital Expenditures | 34.10M |
Log In |
Log In |
Log In |
Log In |
| BSI CALID Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Corporate, Eliminations and Other Operating Income | -121.90M |
Log In |
Log In |
Log In |
Log In |
| Corporate, Eliminations and Other Operating Income Growth | 11.12% |
Log In |
Log In |
Log In |
Log In |
| Total BSI Operating Income | 218.20M |
Log In |
Log In |
Log In |
Log In |
| Total BSI Operating Income Growth | -46.08% |
Log In |
Log In |
Log In |
Log In |
| BEST Operating Income | 34.90M |
Log In |
Log In |
Log In |
Log In |
| BEST Operating Income Growth | 8.05% |
Log In |
Log In |
Log In |
Log In |
| BSI Life Science Operating Income | 337.80M |
Log In |
Log In |
Log In |
Log In |
| BSI Life Science Operating Income Growth | -16.63% |
Log In |
Log In |
Log In |
Log In |
| BSI Nano Operating Income | 2.30M |
Log In |
Log In |
Log In |
Log In |
| BSI Nano Operating Income Growth | -97.89% |
Log In |
Log In |
Log In |
Log In |
| BSI BioSpin Operating Income | 157.80M |
Log In |
Log In |
Log In |
Log In |
| BSI BioSpin Operating Income Growth | -19.45% |
Log In |
Log In |
Log In |
Log In |
| BSI CALID Operating Income | 180.00M |
Log In |
Log In |
Log In |
Log In |
| BSI CALID Operating Income Growth | -14.00% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| United States | 938.50M |
Log In |
Log In |
Log In |
Log In |
| United States Growth | 20.68% |
Log In |
Log In |
Log In |
Log In |
| Germany | 310.70M |
Log In |
Log In |
Log In |
Log In |
| Germany Growth | 10.37% |
Log In |
Log In |
Log In |
Log In |
| Rest of Europe | 873.00M |
Log In |
Log In |
Log In |
Log In |
| Rest of Europe Growth | 24.77% |
Log In |
Log In |
Log In |
Log In |
| Total Asia Pacific | 989.70M |
Log In |
Log In |
Log In |
Log In |
| Total Asia Pacific Growth | 0.07% |
Log In |
Log In |
Log In |
Log In |
| Other Countries | 254.50M |
Log In |
Log In |
Log In |
Log In |
| Other Countries Growth | 17.50% |
Log In |
Log In |
Log In |
Log In |
| China | 471.20M |
Log In |
Log In |
Log In |
Log In |
| China Growth | -10.77% |
Log In |
Log In |
Log In |
Log In |
| Rest of Asia Pacific | 518.50M |
Log In |
Log In |
Log In |
Log In |
| Rest of Asia Pacific Growth | 12.50% |
Log In |
Log In |
Log In |
Log In |